Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of The Effect of Oral Isotretinoin on The Level of Serum YKL40 in Acne Vulgaris Patients

NCT05218486 is registered in ClinicalTrials.gov with Alshimaa Abbas Mohamed Ebrahim as lead sponsor.

NCT NCT05218486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05218486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of The Effect of Oral Isotretinoin on The Level of Serum YKL40 in Acne Vulgaris Patients
Lead sponsor
Alshimaa Abbas Mohamed Ebrahim
Phase
Phase 4
Overall status
Unknown status
Start date
August 1, 2021
Completion date
September 30, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acne vulgaris